Although MMP9 inhibition (by aldosterone antagonists and ACE inhibitors [38]) represents a therapeutic approach for heart failure, atherosclerosis, hypertension, and myocardial infarction, patients with congestive heart failure demonstrate reduced Mmp9 mRNA levels in cardiac biopsies [39]. This evidence concerns the gene ACE and myocardial infarction.